GPR19 and breast cancer: In mesenchymal-like breast cancer, for example, overexpression of GPR19 stimulates E-Cadherin expression and induces an epithelial-like phenotype via the MAPK/ERK1/2 pathway, thereby contributing to carcinogenesis and metastasis.